D2 vs D2 plus para-aortic lymph node dissection for advanced gastric cancer
| dc.authorid | Mehmet Mahir Özmen / 0000-0003-0649-0111 | en_US |
| dc.authorid | Münevver Moran / 0000-0001-8520-7438 | |
| dc.authorscopusid | Mehmet Mahir Özmen / 57211511111 | |
| dc.authorscopusid | Münevver Moran / 58336598000 | |
| dc.authorwosid | Mehmet Mahir Özmen / AAO-2321-2020 | |
| dc.authorwosid | Münevver Moran / FPI-0281-2022 | |
| dc.contributor.author | Özmen, Mehmet Mahir | |
| dc.contributor.author | Zülfikaroğlu, Barış | |
| dc.contributor.author | Özmen, Füsun | |
| dc.contributor.author | Moran, Münevver | |
| dc.contributor.author | Özalp, Necdet | |
| dc.contributor.author | Seçkin, Selda | |
| dc.date.accessioned | 2021-05-21T12:54:34Z | |
| dc.date.available | 2021-05-21T12:54:34Z | |
| dc.date.issued | 2021 | en_US |
| dc.department | İstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
| dc.description.abstract | Abstract Objective: Gastric cancer is a common malignancy worldwide. Effective treatment by interdisciplinary cooperation is important, and surgery still plays an important role. Material and Methods: In a ten-year period, 355 patients were diagnosed to have gastric cancer. One hundred and sixty-two patients with a median (range) age of 58 (23-83) years were eligible for the study. There were 107 patients in D2 and 55 patients in D2 lymphadenectomy plus para-aortic lymph node (PALN) dissection group. The two groups were compared in terms of complications, morbidity, mortality and long-term survival. Results: Length of stay was 12 (8-34) days for D2 and 14 (8-42) days for D2 plus PALND. Total number of operative mortality was 8/162 (5%), and it was not different between the groups. Twenty patients (18%) had complications in D2 group and 9 (17%) patients in D2 plus PALND group. Overall survival was also similar between the groups, but patients with T3-T4 tumors, patients with stage IIIA and IIIB disease had better survival with D2 plus PALN dissection. We found that the depth of invasion, PLN, ratio (PLN/TLN), stage and LND were all prognostic variables. Conclusion: This study showed that D2 plus PALN dissection for advanced gastric cancer can be performed as safely as a standard D2 dissection by experienced surgeons without increasing postoperative morbidity and mortality. D2 plus PALN dissection should be preferred in the advanced stage of the disease (IIIA-IIIB) as it increases the rate of survival. | en_US |
| dc.identifier.citation | : Özmen MM, Zülfikaroğlu B, Özmen F, Moran M, Özalp N, Seçkin S. D2 vs D2 plus para-aortic lymph node dissection for advanced gastric cancer. Turk J Surg 2021; 37 (1): 49-58. | en_US |
| dc.identifier.doi | 10.47717/turkjsurg.2020.4931 | en_US |
| dc.identifier.endpage | 58 | en_US |
| dc.identifier.issn | 2564-6850 | en_US |
| dc.identifier.issn | 2564-7032 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.scopus | 2-s2.0-85108799118 | en_US |
| dc.identifier.scopusquality | N/A | en_US |
| dc.identifier.startpage | 49 | en_US |
| dc.identifier.trdizinid | 503804 | en_US |
| dc.identifier.uri | https://doi.org/10.47717/turkjsurg.2020.4931 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12713/1747 | |
| dc.identifier.volume | 37 | en_US |
| dc.identifier.wos | WOS:000644916100010 | en_US |
| dc.identifier.wosquality | N/A | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.indekslendigikaynak | TR-Dizin | en_US |
| dc.indekslendigikaynak | PubMed | en_US |
| dc.institutionauthor | Özmen, Mehmet Mahir | |
| dc.institutionauthor | Moran, Münevver | |
| dc.language.iso | en | en_US |
| dc.publisher | TURKISH SURGICAL ASSOC | en_US |
| dc.relation.ispartof | TURKISH JOURNAL OF SURGERY | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Advanced Gastric Cancer | en_US |
| dc.subject | D2 Lymphadenectomy | en_US |
| dc.subject | D2 Lymphadenectomy Plus Para-Aortic Lymph Node Dissection | en_US |
| dc.subject | Morbidity | en_US |
| dc.subject | Mortality | en_US |
| dc.subject | Prognosis Extended D2 | en_US |
| dc.subject | Surgical-Treatment | en_US |
| dc.subject | Survival Benefit | en_US |
| dc.subject | Western Patients | en_US |
| dc.subject | D-2 Resections | en_US |
| dc.subject | Risk-Factors | en_US |
| dc.subject | Lymphadenectomy | en_US |
| dc.subject | Surgery | en_US |
| dc.subject | D3 | en_US |
| dc.subject | Gastrectomy | en_US |
| dc.title | D2 vs D2 plus para-aortic lymph node dissection for advanced gastric cancer | en_US |
| dc.type | Article | en_US |
